Show simple item record

dc.contributor.authorNolte, Kerry
dc.contributor.authorDrew, Aurora L.
dc.contributor.authorFriedmann, Peter D.
dc.contributor.authorRomo, Eric
dc.contributor.authorKinney, Linda M.
dc.contributor.authorStopka, Thomas J.
dc.date2022-08-11T08:09:58.000
dc.date.accessioned2022-08-23T16:50:41Z
dc.date.available2022-08-23T16:50:41Z
dc.date.issued2020-12-01
dc.date.submitted2021-02-05
dc.identifier.citation<p>Nolte K, Drew AL, Friedmann PD, Romo E, Kinney LM, Stopka TJ. Opioid initiation and injection transition in rural northern New England: A mixed-methods approach. Drug Alcohol Depend. 2020 Dec 1;217:108256. doi: 10.1016/j.drugalcdep.2020.108256. Epub 2020 Aug 30. PMID: 32947174; PMCID: PMC7769168. <a href="https://doi.org/10.1016/j.drugalcdep.2020.108256">Link to article on publisher's site</a></p>
dc.identifier.issn0376-8716 (Linking)
dc.identifier.doi10.1016/j.drugalcdep.2020.108256
dc.identifier.pmid32947174
dc.identifier.urihttp://hdl.handle.net/20.500.14038/41705
dc.description.abstractBACKGROUND: In rural northern New England, located in the northeastern United States, the overdose epidemic has accelerated with the introduction of fentanyl. Opioid initiation and transition to opioid injection have been studied in urban settings. Little is known about opioid initiation and transition to injection drug use in rural northern New England. METHODS: This mixed-methods study characterized opioid use and drug injection in 11 rural counties in Massachusetts, Vermont, and New Hampshire between 2018 and 2019. People who use drugs completed audio computer-assisted self-interview surveys on substance use and risk behaviors (n = 589) and shared personal narratives through in-depth interviews (n = 22). The objective of the current study is to describe initiation of opioid use and drug injection in rural northern New England. RESULTS: Median age of first injection was 22 years (interquartile range 18-28 years). Key themes from in-depth interviews that led to initiating drug injection included normalization of drug use in families and communities, experiencing trauma, and abrupt discontinuation of an opioid prescription. Other factors that led to a transition to injecting included lower cost, increased effect/ rush, greater availability of heroin/ fentanyl, and faster relief of withdrawal symptoms with injection. CONCLUSIONS: Trauma, normalization of drug use, over-prescribing of opioids, and abrupt discontinuation challenge people who use drugs in rural northern New England communities. Inadequate opioid tapering may increase transition to non-prescribed drug use. The extent and severity of traumatic experiences described highlights the importance of enhancing trauma-informed care in rural areas.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=32947174&dopt=Abstract">Link to Article in PubMed</a></p>
dc.rights© 2020 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectInjection initiation
dc.subjectNorthern New England
dc.subjectOpioid initiation
dc.subjectPeople who use drugs
dc.subjectRural opioid use
dc.subjectTrauma
dc.subjectPublic Health
dc.subjectSubstance Abuse and Addiction
dc.titleOpioid initiation and injection transition in rural northern New England: A mixed-methods approach
dc.typeJournal Article
dc.source.journaltitleDrug and alcohol dependence
dc.source.volume217
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=5526&amp;context=oapubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/4496
dc.identifier.contextkey21479081
refterms.dateFOA2022-08-23T16:50:41Z
html.description.abstract<p>BACKGROUND: In rural northern New England, located in the northeastern United States, the overdose epidemic has accelerated with the introduction of fentanyl. Opioid initiation and transition to opioid injection have been studied in urban settings. Little is known about opioid initiation and transition to injection drug use in rural northern New England.</p> <p>METHODS: This mixed-methods study characterized opioid use and drug injection in 11 rural counties in Massachusetts, Vermont, and New Hampshire between 2018 and 2019. People who use drugs completed audio computer-assisted self-interview surveys on substance use and risk behaviors (n = 589) and shared personal narratives through in-depth interviews (n = 22). The objective of the current study is to describe initiation of opioid use and drug injection in rural northern New England.</p> <p>RESULTS: Median age of first injection was 22 years (interquartile range 18-28 years). Key themes from in-depth interviews that led to initiating drug injection included normalization of drug use in families and communities, experiencing trauma, and abrupt discontinuation of an opioid prescription. Other factors that led to a transition to injecting included lower cost, increased effect/ rush, greater availability of heroin/ fentanyl, and faster relief of withdrawal symptoms with injection.</p> <p>CONCLUSIONS: Trauma, normalization of drug use, over-prescribing of opioids, and abrupt discontinuation challenge people who use drugs in rural northern New England communities. Inadequate opioid tapering may increase transition to non-prescribed drug use. The extent and severity of traumatic experiences described highlights the importance of enhancing trauma-informed care in rural areas.</p>
dc.identifier.submissionpathoapubs/4496
dc.contributor.departmentGraduate School of Biomedical Sciences
dc.contributor.departmentDepartment of Population and Quantitative Health Sciences
dc.source.pages108256


Files in this item

Thumbnail
Name:
Publisher version
Thumbnail
Name:
1_s2.0_S037687162030421X_main.pdf
Size:
1.845Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

© 2020 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Except where otherwise noted, this item's license is described as © 2020 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).